… For nonhospitalized patients with mild-to-moderate Covid-19… for patients at high risk for
progression to severe Covid-19. … the risk of progression to severe Covid-19, 11-13 limitations …

… Although the low rates of VTE reported in our study do not support the universal use of
antithrombotic agents in nonhospitalized patients with COVID-19, our results support the …

… in a population-based cohort of non-hospitalized subjects 1.5–6 months after COVID-19.
It was a mixed postal/web survey of all non-hospitalized patients ≥18 years with a positive …

… whether non-hospitalized COVID-19 patients reported a … non-hospitalized patients were not
protected from the COVID-19s … recent report of non-hospitalized COVID-19 patients, where 55…

… younger than the hospitalized Covid-19 patients at our institution. Due to the shortcomings
of using antibodies to establish the diagnosis of Covid-19 in non-hospitalized patients, we are …

… Objectives: This study aimed to compare the scope of early complications after COVID-19
in patients who had the disease with and without hospitalization. Patients and Methods: This …

… patients from relapse/reinfection. Four of 96 (4.16%) pneumonia patients and three of 57 (5.26%)
nonpneumonia patients … large subset of nonhospitalized COVID‐19 patients in Wuhan …

… syndrome coronavirus 2 (SARS-CoV-2) infection (Long-COVID) … COVID-19 infection
and to assess their impact on prolonged symptoms in non-hospitalized patients with COVID-19…

… taken by any COVID-19 patient considering this intervention. … reduce symptom burden in
patients with COVID-19, we are … saline irrigations in non-hospitalized COVID-19 patients as a …

… distinct from other LPV/r COVID-19 clinical trials. First, we focused on non-hospitalized patients
rather than those admitted to the hospital for COVID-19 who may be more severely ill and …